We determined the association of postsurgical plasma adiponectin levels with TIL densities, 25(OH)D, clinicopathological features, and clinical outcome in patients with stage III colon cancers from a phase III adjuvant trial of FOLFOX-based chemotherapy (NCCTG N0147 [Alliance]) (23). This evidence concerns the gene ADIPOQ and colonic neoplasm.